# Delpharm Dijon – FDA Inspection, May 31, 2024

Source: https://www.keypedia.com/records/fda_inspections/delpharm-dijon/48fc0cb0-6971-42cf-ba56-e0f08bc7a3ac
Source feed: FDA_Inspections

> FDA inspection 1240699 of Delpharm Dijon, May 31, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240699
- Company Name: Delpharm Dijon
- Inspection Date: 2024-05-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Documents

- FDA Inspection 1229926 - 2021-11-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jolanna-a-norton/5501fea4-4bfd-434c-b2aa-fcf94444f684)
- [Investigator](https://www.keypedia.com/people/liya-tang/f4103ebd-2bdd-48c7-b1c1-07b5421e8b64)

Company: https://www.keypedia.com/companies/delpharm-dijon/8f766752-64b7-4166-b421-2fbe7803560d

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
